{"product_id":"strides-marketing-mix","title":"Strides Pharma Science Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eStrides Pharma Science masterfully leverages its product portfolio, competitive pricing, strategic global distribution, and targeted promotional campaigns to solidify its market presence. Understanding these core 4Ps is crucial for anyone seeking to grasp their success. \u003c\/p\u003e\n\u003cp\u003eGo beyond the basics—get access to an in-depth, ready-made Marketing Mix Analysis covering Strides Pharma Science's Product, Price, Place, and Promotion strategies. Ideal for business professionals, students, and consultants looking for strategic insights. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiverse Pharmaceutical Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science boasts a comprehensive pharmaceutical product range, encompassing injectables, softgels, oral solids, liquids, creams, ointments, and sachets. This extensive offering ensures they can address a wide array of patient requirements and therapeutic needs across international markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFocus on Niche and Complex Formulations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science strategically focuses on niche and technically complex pharmaceutical formulations. This specialization provides a significant competitive advantage, particularly in highly regulated markets such as the United States, Europe, and Australia.  Their capability in developing challenging drug delivery systems and difficult-to-manufacture products creates higher barriers to entry for competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTherapeutic Area Expertise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science demonstrates significant strength across key therapeutic areas, notably in anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments. This deep expertise is particularly crucial for their institutional business, where consistent supply and quality are paramount.  The company’s commitment extends to providing essential healthcare solutions for a broad spectrum of diseases, impacting global health initiatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Development and Manufacturing (CDMO) Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrides Pharma Science is strategically expanding its operations into the Contract Development and Manufacturing Organization (CDMO) sector, a move that significantly bolsters its Product offering. This expansion focuses on high-growth areas like biologics, complex injectables, and advanced oral technologies. By offering these specialized services, Strides aims to become a preferred partner for other pharmaceutical companies seeking to outsource their development and manufacturing needs, thereby diversifying its revenue streams and leveraging its existing infrastructure and R\u0026amp;D prowess.\u003c\/p\u003e\n\u003cp\u003eThe CDMO services represent a crucial element of Strides' 'Product' strategy, allowing them to monetize their robust manufacturing capabilities and scientific expertise beyond their own branded products. This segment is particularly attractive given the global CDMO market's projected growth. For instance, the biologics CDMO market alone was valued at approximately $18.5 billion in 2023 and is expected to see a compound annual growth rate (CAGR) of around 10-12% through 2030, indicating substantial opportunity.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eLeveraging Expertise:\u003c\/strong\u003e Strides is capitalizing on its established R\u0026amp;D and manufacturing infrastructure to offer specialized services in biologics, complex injectables, and oral technologies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Opportunity:\u003c\/strong\u003e The global CDMO market is experiencing robust growth, with the biologics segment alone projected for significant expansion in the coming years.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Diversification:\u003c\/strong\u003e This move allows Strides to diversify its revenue streams by serving a broader client base of pharmaceutical companies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e By focusing on complex and high-demand areas, Strides aims to differentiate itself and capture a significant share of the CDMO market.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContinuous  Pipeline and R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrides Pharma Science demonstrates a robust commitment to its Continuous Pipeline and R\u0026amp;D strategy, essential for its long-term growth. This focus ensures a consistent flow of new products, bolstering market presence and competitive advantage.\u003c\/p\u003e\n\u003cp\u003eThe company actively pursues new product approvals and cultivates strategic alliances. These efforts are designed to broaden its product portfolio and expand its reach into new and existing markets, creating a predictable stream of future revenue opportunities.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePipeline Strength:\u003c\/strong\u003e Strides Pharma maintains a diverse pipeline, with a significant number of products in various stages of development, aiming for timely regulatory approvals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eR\u0026amp;D Investment:\u003c\/strong\u003e The company consistently allocates resources to research and development, focusing on complex generics and differentiated products to enhance its market offerings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Partnerships:\u003c\/strong\u003e For the fiscal year ending March 31, 2024, Strides Pharma continued to explore and solidify strategic collaborations to accelerate product development and market penetration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuture Growth Driver:\u003c\/strong\u003e This continuous pipeline and R\u0026amp;D approach is a cornerstone of Strides Pharma's strategy to achieve sustainable revenue growth and maintain a leading position in the pharmaceutical sector.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma Product Strategy: Broad Portfolio, CDMO Expansion, R\u0026amp;D Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science's product strategy is characterized by a broad portfolio, including injectables, softgels, and oral solids, catering to diverse therapeutic needs. Their focus on niche and technically complex formulations, particularly in regulated markets like the US and Europe, provides a significant competitive edge.\u003c\/p\u003e\n\u003cp\u003eThe company's expansion into the Contract Development and Manufacturing Organization (CDMO) sector, especially in high-growth areas like biologics and complex injectables, is a key product differentiator. This move leverages their manufacturing capabilities and scientific expertise, tapping into a global CDMO market projected to grow substantially.\u003c\/p\u003e\n\u003cp\u003eStrides Pharma Science's commitment to a robust R\u0026amp;D pipeline and continuous product development is central to its product offering. This ensures a steady stream of new and differentiated products, supported by strategic partnerships and investments in research, aiming for sustained revenue growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct Focus\u003c\/th\u003e\n\u003cth\u003eKey Therapeutic Areas\u003c\/th\u003e\n\u003cth\u003eCDMO Service Areas\u003c\/th\u003e\n\u003cth\u003eR\u0026amp;D Investment (FY24 est.)\u003c\/th\u003e\n\u003cth\u003eMarket Reach\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInjectables, Softgels, Oral Solids, Liquids, Creams, Ointments, Sachets\u003c\/td\u003e\n\u003ctd\u003eAnti-retroviral, Anti-malarial, Anti-tuberculosis, Hepatitis\u003c\/td\u003e\n\u003ctd\u003eBiologics, Complex Injectables, Advanced Oral Technologies\u003c\/td\u003e\n\u003ctd\u003eSignificant allocation towards complex generics and differentiated products\u003c\/td\u003e\n\u003ctd\u003eUS, Europe, Australia, Global Institutional Markets\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThis analysis offers a comprehensive examination of Strides Pharma Science's marketing mix, detailing their product portfolio, pricing strategies, distribution channels, and promotional efforts.\u003c\/p\u003e\n\u003cp\u003eIt's designed for professionals seeking to understand Strides Pharma Science's market positioning and competitive advantages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eSimplifies complex marketing strategies into actionable insights, alleviating the pain of strategic confusion for Strides Pharma Science.\u003c\/p\u003e\n\u003cp\u003eProvides a clear, concise overview of Strides Pharma Science's 4Ps, easing the burden of detailed analysis for busy stakeholders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Market Presence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science boasts a significant global footprint, extending its reach into both highly regulated and emerging markets. In the fiscal year 2024, the company reported that its operations in regulated markets, such as the United States and Europe, continued to be a primary revenue driver, contributing over 60% of its total sales.\u003c\/p\u003e\n\u003cp\u003eSimultaneously, Strides is strategically expanding its presence in key emerging markets, with a particular focus on Africa and Asia-Pacific. By the end of 2024, they had established a robust distribution network in over 25 African countries, aiming to capture a larger share of the growing pharmaceutical demand in the region.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Manufacturing Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science boasts an impressive manufacturing network comprising eight facilities strategically positioned across India, Singapore, Italy, the United States, and Kenya. This extensive global presence, with key locations in Bengaluru, Puducherry, Chennai, Milan, Florida, and Nairobi, underscores the company's capacity to produce a wide array of pharmaceutical products.  For the fiscal year ending March 31, 2024, Strides reported a robust revenue growth, partly fueled by its efficient manufacturing operations and ability to meet global demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science employs a multi-pronged approach to distribution, reaching diverse markets. In regulated regions like the UK, they leverage direct wholesalers, the National Health Service (NHS), and Clinical Commissioning Groups (CCGs). This ensures broad access to their pharmaceutical products.\u003c\/p\u003e\n\u003cp\u003eBeyond these core channels, Strides actively participates in institutional business. This involves supplying essential medicines for donor-funded aid projects and global procurement agencies, demonstrating a commitment to broader public health initiatives. For instance, in 2023, Strides reported a significant portion of its revenue derived from institutional sales in emerging markets, highlighting the importance of these channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartnerships and Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStrides Pharma Science actively cultivates strategic partnerships and alliances to broaden its product portfolio and enhance market penetration. These collaborations are crucial for co-developing new treatments and extending the reach of vital medicines into underserved healthcare sectors.\u003c\/p\u003e\n\u003cp\u003eA prime example of this strategy is the significant 10-year supply agreement inked with Arrotex, a prominent generic pharmaceutical company in Australia. This partnership is designed to ensure a consistent supply of Strides' products, bolstering its presence in a key international market.\u003c\/p\u003e\n\u003cp\u003eThe company's approach to partnerships is multifaceted, aiming to leverage the strengths of its associates for mutual growth. This includes:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpanding Product Offerings:\u003c\/strong\u003e Collaborating with partners to bring a wider array of pharmaceutical products to market.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnhancing Market Access:\u003c\/strong\u003e Utilizing partner networks to reach new geographical regions and patient populations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCo-Development Initiatives:\u003c\/strong\u003e Jointly developing new drug formulations and delivery systems to address critical healthcare needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong-Term Supply Agreements:\u003c\/strong\u003e Securing stable revenue streams and market share through enduring supply contracts, such as the one with Arrotex.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStrides Pharma Science prioritizes supply chain efficiency to enhance customer convenience and streamline logistics. A key indicator of this focus is their improved cash-to-cash cycle, demonstrating effective management of inventory and distribution processes. This operational strength directly supports robust operating cash generation.\u003c\/p\u003e\n\u003cp\u003eThe company's commitment to supply chain optimization is evident in its financial performance. For instance, Strides reported a reduction in its cash conversion cycle, a testament to their agile inventory management and efficient sales processes. This operational excellence translates into better working capital utilization.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eCash-to-Cash Cycle Improvement:\u003c\/strong\u003e Strides has seen a tangible reduction in its cash-to-cash cycle, indicating faster conversion of investments in inventory and other resources into cash from sales.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInventory Management:\u003c\/strong\u003e Efficient handling of inventory reduces holding costs and minimizes the risk of obsolescence, contributing to better financial health.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLogistics Optimization:\u003c\/strong\u003e Streamlined distribution networks ensure timely delivery of products, enhancing customer satisfaction and reducing transportation expenses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOperating Cash Flow:\u003c\/strong\u003e The improved supply chain directly fuels stronger operating cash generation, providing financial flexibility for growth and investment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Market Strategy: Manufacturing, Distribution, and Strategic Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrides Pharma Science's place strategy centers on a dual approach: maintaining a strong presence in regulated markets like the US and Europe, which accounted for over 60% of sales in FY24, while simultaneously expanding into emerging markets, particularly in Africa and Asia-Pacific.\u003c\/p\u003e\n\u003cp\u003eTheir extensive manufacturing network, with eight facilities across India, Singapore, Italy, the US, and Kenya, ensures production capacity to meet global demand, contributing to their robust revenue growth reported for the fiscal year ending March 31, 2024.\u003c\/p\u003e\n\u003cp\u003eDistribution channels are diverse, including direct wholesalers and the NHS in the UK, alongside institutional business supplying aid projects and procurement agencies, a channel that significantly contributed to revenue in emerging markets in 2023.\u003c\/p\u003e\n\u003cp\u003eStrategic partnerships, like the 10-year supply agreement with Arrotex in Australia, are key to broadening their product portfolio and enhancing market access in crucial international territories.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eStrides Pharma Science 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual document you’ll receive instantly after purchase—no surprises. This comprehensive Strides Pharma Science 4P's Marketing Mix Analysis details their Product, Price, Place, and Promotion strategies. You can trust that the insights and information you see are exactly what you'll get.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55612299805049,"sku":"strides-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/strides-marketing-mix.png?v=1754770061","url":"https:\/\/matrixbcg.com\/products\/strides-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}